SLRN: Acelyrin, Inc. Company Short-Term Debt

The market for targeted treatment of autoimmune pathologies is currently expanding rapidly, offering colossal opportunities due to a shortage of effective therapies. Acelyrin, Inc. (SLRN) operates in this niche, developing therapies for patients with severe inflammatory processes, including psoriasis. The available price action reflects a metric of 0.00. The company's growth is supported by the development of isokibep and the availability of capital to complete testing.

SLRN (Acelyrin Inc.) Company Short-Term Debts history from 02/21/2024 to 05/31/2025

Analytical breakdowns and data insights for company ACELYRIN Inc. (SLRN)

- current quotes and average value forecast:
Price Chart ACELYRIN|SLRN - Fair Value Consensus
- market capitalization information:
Market Value Acelyrin, Inc.|SLRN - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share ACELYRIN|SLRN - Book Capitalization|Market Cap to Net Assets Ratio acelyrin.com|SLRN - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Acelyrin, Inc.|SLRN - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Acelyrin, Inc.|SLRN - Company Cumulative Indebtedness|Debts to Book Capitalization Acelyrin, Inc.|SLRN - Company Long-Term Loans and Borrowings|Company Short-Term Debts ACELYRIN
Summary company analytics:ACELYRIN (SLRN)

Short-term debt aggregates all creditor obligations with a maturity of up to one year, measuring current liquidity and the issuer's default risk. By analyzing the short-term debt burden metric on GURU.Markets, an investor can assess the ability of Acelyrin, Inc. (SLRN) to fund the development of innovative IL-17A blocker proteins until the company can monetize its significant pricing power in the psoriasis and arthritis therapy market.

Competing companies

HLN - Company Short-Term Debt|Company Short-Term Loans and Borrowings KVUE (Kenvue Inc)|Verona Pharma Corp (VRNA) - Company Short-Term Debt|Company Current Liabilities Jyong Bio|LGND (Ligand Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts amneal.com|Company Current Liabilities PRGO (Perrigo)|ALVO (Alvotech S.A.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Liquidia Technologies LQDA|Galapagos Corp (GLPG) - Short-Term Debt|ANIP: Company Current Liabilities|mannkindcorp.com - Amount of Current Liabilities|AMPH: Company Short-Term Debts|Pacira Pharmaceuticals - Company Short-Term Loans and Borrowings|SPRY (ARS Pharma) - Company Short-Term Debts|Short-Term Debt Theravance Corp TBPH|Company Short-Term Debt Aquestive Therapeutics (AQST)|SCPH (scpharmaceuticals.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts TECX (Tectonic Therapeutic)|Company Short-Term Debts Tonix Pharma TNXP|SXT China - Company Short-Term Debts|Eupraxia Pharmaceuticals (EPRX) - Company Current Liabilities|BHST: Company Short-Term Debts|Short-Term Debt invizyne.com (EXOZ)|Company Short-Term Debt Oramed|Company Short-Term Debt ENTX|Company Current Liabilities HYFT (MindWalk)|ABVC - Short-Term Debt|Company Short-Term Debt Cumberland Pharmaceuticals CPIX|Company Short-Term Loans and Borrowings QNTM|FibroGen - Company Short-Term Debts|Short-Term Debt Volume Telomir Pharmaceuticals Inc TELO|ranitherapeutics.com (RANI) - Company Short-Term Debt|Company Short-Term Indebtedness SNYR|Company Current Liabilities RLYB|LEXX: Company Short-Term Loans and Borrowings|Company Short-Term Debts PULM|Short-Term Debt Volume ftzy.com.cn|Company Short-Term Debt Aptorum Group APM|LYRA: Company Short-Term Indebtedness|Impact BioMedical - Company Short-Term Debts|TNF Pharmaceuticals (TNFA) - Company Current Liabilities|YCBD (cbdmd.com) - Company Current Liabilities|PRFX - Short-Term Debt Volume|Company Short-Term Debt Altamira Therapeutics Ltd|Lipella Pharma (LIPO) - Short-Term Debt Volume|Company Short-Term Debt OptiNose, Inc. (OPTN)|Company Short-Term Debt PIRS (pieris.com)|Company Short-Term Debt Procaps PROC|Company Short-Term Loans and Borrowings PTPI|QLI - Company Short-Term Debt|TFFP (TFF Pharmaceuticals, Inc) - Company Short-Term Indebtedness